Evidence map›Paper›PMID 32356548›Full record

ReviewChemical Society reviews2020

QSAR without borders.

Eugene N Muratov, Jürgen Bajorath, Robert P Sheridan, Igor V Tetko, Dmitry Filimonov, Vladimir Poroikov, Tudor I Oprea, Igor I Baskin, Alexandre Varnek, Adrian Roitberg and 9 more

Erratum issuedAbstract readHistorical ArticleReview
In one paragraph

Review in Chemical Society reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 275 papers.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

275 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Artificial intelligence-assisted lead optimization in drug discovery: bridging computational advances and translational challenges.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. AI-driven drug design: a comprehensive review.Journal of computer-aided molecular design · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Eugene N MuratovUNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. alex_tropsha@unc.edu.
Jürgen Bajorath
Robert P Sheridan
Igor V Tetko
Dmitry Filimonov
Vladimir Poroikov
Tudor I Oprea
Igor I Baskin
Alexandre Varnek
Adrian Roitberg
Olexandr Isayev
Stefano Curtarolo
Denis Fourches
Yoram Cohen
Alan Aspuru-Guzik
David A Winkler
Dimitris Agrafiotis
Artem Cherkasov
Alexander Tropsha

Funding

Machine Learning Model Validation for AD/ADRDU24CA224370 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2018 to 2023
$6.4M
Resource Dissemination and Outreach Center for Illuminating the Druggable GenomeU24TR002278 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHURER, STEPHAN C, SKLAR, LARRY A. · 2018 to 2023
$3.7M
Illuminating the Druggable Genome by Knowledge GraphsU01CA239108 · NCI · JACKSON LABORATORY · PI MUNGALL, CHRISTOPHER J, OPREA, TUDOR I · 2019 to 2021
$1.7M
Drug Repurposing for Cancer Therapy: From Man to Molecules to ManU01CA207160 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TROPSHA, ALEXANDER · 2016 to 2018
$1.2M
NCATS NIH HHS U24 TR002278NCI NIH HHS U01 CA207160NCI NIH HHS U01 CA239108NCI NIH HHS U24 CA224370
6 · The paper itself

Abstract

Prediction of chemical bioactivity and physical properties has been one of the most important applications of statistical and more recently, machine learning and artificial intelligence methods in chemical sciences. This field of research, broadly known as quantitative structure-activity relationships (QSAR) modeling, has developed many important algorithms and has found a broad range of applications in physical organic and medicinal chemistry in the past 55+ years. This Perspective summarizes recent technological advances in QSAR modeling but it also highlights the applicability of algorithms, modeling methods, and validation practices developed in QSAR to a wide range of research areas outside of traditional QSAR boundaries including synthesis planning, nanotechnology, materials science, biomaterials, and clinical informatics. As modern research methods generate rapidly increasing amounts of data, the knowledge of robust data-driven modelling methods professed within the QSAR field can become essential for scientists working both within and outside of chemical research. We hope that this contribution highlighting the generalizable components of QSAR modeling will serve to address this challenge.

Indexed as

AlgorithmsAnimalsArtificial IntelligenceChemistry, PharmaceuticalDatabases, FactualDrug DesignDrug-Related Side Effects and Adverse ReactionsHistory, 20th CenturyHistory, 21st CenturyHumansModels, MolecularPharmaceutical PreparationsQuantitative Structure-Activity RelationshipQuantum TheoryReproducibility of ResultsPharmaceutical Preparations

Identifiers

PMID32356548
PMCPMC8008490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.